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The main finding was that the third-trimester weekly weight
gain was significantly higher in primigravidas, whereas they
delivered lighter newborns. On the other hand, multiparas had
a significantly higher booking weight; they delivered
significantly heavier babies but had a significantly lower third-
trimester weekly weight gain. End-pregnancy weight depends
on the pre-pregnancy weight and the pregnancy weight gain.
In most multiparas, the mean pre-pregnancy weight increases
with age and parity. The effect of parity is attributed mainly to
the retention of weight from the previous pregnancy; there
could also be a general weight gain over time unrelated to
pregnancies.
According to standard textbooks, the average weekly weight
gain in the second half of pregnancy is around one pound
(range: 0.30 - 0.49 kg).9 A weight gain of less than 0.27 - 0.22
kg/week is considered inadequate.10 Reports from developing
countries show wide variations in pregnancy weight gain. In
the Philippines, the third-trimester weekly weight gain is 0.27
± 0.25 kg.11 In rural Tanzania, the mean end-pregnancy weight
is between 17% and 20% of the booking weight (around the
24th week) for an average birth weight of 2 920 g (range: 2 640-
3 085).12 These data and our survey contradict the statement
made by Rössner5 that in the developing world women
generally gain less weight. 
As expected, in our series neonates born to multiparas were
significantly heavier than those born to primiparas. The
correlation between third-trimester weekly weight gain and
birth weight was poor (1.2 and 0.6%) and so was the
correlation between birth weight and parity (1.8%). The
strongest association was found between maternal booking and
end-pregnancy weight and birth weight. This suggests that the
link between birth weight and birth order is not independent
but (at least partly) the result of a progressive maternal weight
increase over time that is partly attributable to a retention of
weight from the previous pregnancy. Alternative methods of
assessing fetal growth, such as serial symphysis-fundus
measurements, are more useful than serial weight
measurements.
Louis-Jacques van Bogaert
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To the Editor: Viruses are a common cause of respiratory tract
infections in young children, and the most frequently isolated
viruses from nasopharageal aspirates (NPA) are respiratory
syncytial virus (RSV), influenza viruses, parainfluenza viruses,
adenovirus, cytomegalovirus, enteroviruses, rhinoviruses and
coronaviruses. There is, however, a proportion of infections for
which no aetiological agent can be found. Recently a novel
virus, human metapneumovirus (HMPV), was isolated from
young children in the Netherlands with respiratory tract
disease.1 Since then numerous PCR-based studies from around
the world have confirmed this disease association in both
adults and children, with prevalences ranging from 1.5% to
43%.2-8 Seroprevalence studies have shown that all children
above 10 years old have been exposed to the virus and are
seropositive.1,9 The virus is a new human pathogen of the genus
Metapneumovirus, family Paramyxoviridae.1,10
This study was undertaken to determine HMPV infection in
a paediatric group hospitalised with respiratory tract infection
in Cape Town, South Africa. The occurrence of HMPV was
determined over two consecutive winter seasons (April -
August 2001, and April - August 2002). In addition the extent
of HMPV infection in the summer months (January - April
2003) was also examined. The study population consisted of
children under the age of 3 years admitted to the Red Cross
War Memorial Children's Hospital with respiratory disease and
from whom none of the common respiratory viruses were
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isolated in routine viral culture. Thus in the 2001 and 2002
winter seasons, 64 and 69 children were investigated
respectively, while 51 children were investigated in the 2003
summer season. In addition possible HMPV co-infection was
assessed in 20 children from the 2001 winter season. RNA was
extracted from NPA using the QIAamp Viral RNA mini kit
(QIAGEN GmbH, Hilden, Germany). The RNA was reverse
transcribed into cDNA using random primers and Superscript
III RNase H- reverse transcriptase, according to the
manufacturer's instructions (Invitrogen Ltd., Paisley, UK). The
quality of the cDNA for PCR amplification was assessed using
β globin primers (GH20 and PC04). Only β globin-positive
samples were used for HMPV detection. PCR was performed
using 10 µl cDNA and primers to the fusion (F) gene as
previously described.2 The sensitivity of the assay was
increased with the use of nested primers (sense
5'CTGAACTAGCCAGAGCTGT) and (antisense
5'CATTGATTCCTGCTGCTGTGTC) using the same
amplification conditions. Amplicons (354bp) from positive
samples were cloned into pGEM-T vector (Promega
Corporation, Madison, USA), and plasmid DNA was extracted
using QIAprep Spin Miniprep kit (QIAGEN, GmbH, Hilden,
Germany). The DNA was sequenced and sequences were
aligned with HMPV fusion gene sequences from the GenBank
database using the CLUSTAL_X software package. A phylo-
genetic tree was constructed using the neighbour-joining
method to determine the genotype clusters circulating in this
paediatric group.
In the 2001 winter season 52/64  samples (81%) were β
globin-positive, and of those 4 (7.7%) were HMPV-positive.
Among the 20 children with proven infections with another
respiratory virus, HMPV RNA was found in 1 child co-infected
with RSV. In the 2002 winter season 91% (63/69) of the NPA
samples were β globin-positive and in 12 (19%) HMPV RNA
was detected.  Eighty-eight per cent (45/51) of the summer
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Fig. 1. Phylogenetic tree generated by neighbour-joining analysis of the fusion gene of HMPV. Bootstrap values of greater than 75% are indicated
on the nodes of the tree. The branch lengths are proportional to the evolutionary distances as shown on the scale. Sequences from this study are
represented in bold type. Representative sequences from GenBank are indicated by accession numbers.
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2003 season NPA samples were used to detect HMPV and in
2.2% (1/45) the viral RNA was found. 
Phylogenetic analysis of worldwide isolates of HMPV
confirmed two genetically distinct clusters as previously
described.1,2,4 In both the 2001 and 2002 winter seasons HMPV
from only one cluster was circulating in this study population
and this cluster included AY152847 (Spain), NC_0041489
(Netherlands) and AY145301 (Canada).  The single summer
2003 sequence clustered with the 2001 sequences (Fig. 1).
The results of this study confirm the association of HMPV
with respiratory diseases in children and indicate that up to
19% of children hospitalised with respiratory symptoms in
Cape Town are infected with HMPV in the absence of any of
the other more common viral respiratory pathogens. The
prevalence differed significantly in the two winter seasons
under study, with a figure of 7.7% for 2001 and 19% for 2002.
The latter prevalence figure is one of the highest reported in
the literature, although a recent study from Italy8 has shown
that over 40% of nasal swabs from infants with acute
respiratory tract infections were positive for HMPV. The
HMPV was found more frequently in the winter months than
in summer (19% versus 2.2%); however, the virus in circulation
in summer also appeared to be responsible for respiratory
symptoms requiring hospitalisation. Although only a small
group was examined for HMPV co-infection, it was
infrequently detected and is in line with previous reports.4,7
Only one of the two major HMPV genotypes was identified
in these patients, but with continued surveillance the
circulation of the other major group may be found. 
The high prevalence of HMPV in children hospitalised with
acute respiratory tract disease indicates that HMPV is an
important respiratory pathogen in the Cape Town area and
should be considered a causative agent in the absence of
detection of the other more commonly associated respiratory
viruses. 
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